null

SMILES COc1cc(OC2CCN(CC2)C(C)=O)ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2ccccc12

InChI Key InChIKey=WDERJSQJYIJOPD-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 50029649   

TargetVasopressin V1a receptor(RAT)
DrugMolDesign

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataKi:  3.70nMAssay Description:Displacement of [3H]-vasopressin from vasopressin V1a receptor in rat liver tissueMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20R9PMZPubMed
TargetVasopressin V1a receptor(RAT)
DrugMolDesign

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataKi:  3.70nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in rat liverMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZW1JXCPubMed
TargetVasopressin V1a receptor(Homo sapiens (Human))
GlaxoSmithKline

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataKi: <2.00E+3nMAssay Description:Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2C24VRFPubMed
TargetVasopressin V1a receptor(Homo sapiens (Human))
GlaxoSmithKline

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataKi:  3.20E+3nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in human plateletsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZW1JXCPubMed
TargetVasopressin V1a receptor(Homo sapiens (Human))
GlaxoSmithKline

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataKi:  3.20E+3nMAssay Description:Displacement of [3H]-vasopressin from vasopressin V1a receptor in human liver tissueMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20R9PMZPubMed
TargetVasopressin V1a receptor(Homo sapiens (Human))
GlaxoSmithKline

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataKi:  3.20E+3nMAssay Description:Binding affinity towards human Vasopressin V1a receptor by using functional assayMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23N22K9PubMed
TargetVasopressin V1a receptor(Homo sapiens (Human))
GlaxoSmithKline

Curated by ChEMBL
LigandPNGBDBM50029649(1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzo...)copy SMILEScopy InChI
Affinity DataEC50:  3.20E+3nMAssay Description:Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2FX7BD4PubMed